Yali Chen, Tiewei Xu, Qin Zhen, Changping Gan, Yan Kang, Peng Ji
{"title":"早期左心减压对急性左心衰竭犬模型肺的保护作用,该模型采用静脉动脉体外膜氧合治疗。","authors":"Yali Chen, Tiewei Xu, Qin Zhen, Changping Gan, Yan Kang, Peng Ji","doi":"10.3389/fcvm.2025.1545903","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Nearly 30% of patients who undergo venoarterial extracorporeal membrane oxygenation (VA-ECMO) suffer pulmonary edema, which increases mortality risk. Left heart decompression is widely considered an effective way to counter left ventricular dilatation during VA-ECMO, but whether decompression can protect the lung or improve prognosis is unclear. We investigated this question using a canine model of acute left heart failure being treated through VA-ECMO.</p><p><strong>Methods: </strong>The left anterior descending artery was ligated in 12 beagles to induce acute heart failure, and starting 1 h later, animals were treated using femoral-femoral VA-ECMO for 3 h. In half the animals, left heart decompression was initiated concurrently with VA-ECMO. In the other half, decompression was initiated 1 h after VA-ECMO began. The \"early decompression\" and \"late decompression\" groups were compared in terms of pulmonary function, cardiac function, hemodynamics, histopathology and inflammatory responses.</p><p><strong>Results: </strong>Early initiation of decompression led to significantly higher PaO<sub>2</sub> (63.27 ± 3.35 vs. 24.70 ± 4.44 mmHg, <i>P</i> = 0.030), lower PaCO<sub>2</sub> (31.65 ± 2.87 vs. 41.02 ± 4.88 mmHg, <i>P</i> = 0.014), smaller alveolar-arterial oxygen pressure difference, weaker transpulmonary pressure gradient (3.67 ± 3.14 vs. 13.35 ± 4.26 mmHg, <i>P</i> = 0.017), milder pulmonary edema, lower levels of pro-inflammatory cytokines TNF-α and IL-6 in lungs, lower left atrial pressure, lower left ventricular end diastolic pressure, lower mean pulmonary artery pressure, and higher mean arterial pressure. Earlier decompression also led to milder pulmonary blood congestion and pulmonary histopathology.</p><p><strong>Conclusion: </strong>Left heart decompression, when initiated as soon as possible during VA-ECMO, can protect pulmonary function by alleviating inflammatory responses in the lung, improving hemodynamics and lowering ventricular filling pressure.</p>","PeriodicalId":12414,"journal":{"name":"Frontiers in Cardiovascular Medicine","volume":"12 ","pages":"1545903"},"PeriodicalIF":2.8000,"publicationDate":"2025-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12504222/pdf/","citationCount":"0","resultStr":"{\"title\":\"Early left heart decompression protects the lungs in a canine model of acute left heart failure being treated with venoarterial extracorporeal membrane oxygenation.\",\"authors\":\"Yali Chen, Tiewei Xu, Qin Zhen, Changping Gan, Yan Kang, Peng Ji\",\"doi\":\"10.3389/fcvm.2025.1545903\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Nearly 30% of patients who undergo venoarterial extracorporeal membrane oxygenation (VA-ECMO) suffer pulmonary edema, which increases mortality risk. Left heart decompression is widely considered an effective way to counter left ventricular dilatation during VA-ECMO, but whether decompression can protect the lung or improve prognosis is unclear. We investigated this question using a canine model of acute left heart failure being treated through VA-ECMO.</p><p><strong>Methods: </strong>The left anterior descending artery was ligated in 12 beagles to induce acute heart failure, and starting 1 h later, animals were treated using femoral-femoral VA-ECMO for 3 h. In half the animals, left heart decompression was initiated concurrently with VA-ECMO. In the other half, decompression was initiated 1 h after VA-ECMO began. The \\\"early decompression\\\" and \\\"late decompression\\\" groups were compared in terms of pulmonary function, cardiac function, hemodynamics, histopathology and inflammatory responses.</p><p><strong>Results: </strong>Early initiation of decompression led to significantly higher PaO<sub>2</sub> (63.27 ± 3.35 vs. 24.70 ± 4.44 mmHg, <i>P</i> = 0.030), lower PaCO<sub>2</sub> (31.65 ± 2.87 vs. 41.02 ± 4.88 mmHg, <i>P</i> = 0.014), smaller alveolar-arterial oxygen pressure difference, weaker transpulmonary pressure gradient (3.67 ± 3.14 vs. 13.35 ± 4.26 mmHg, <i>P</i> = 0.017), milder pulmonary edema, lower levels of pro-inflammatory cytokines TNF-α and IL-6 in lungs, lower left atrial pressure, lower left ventricular end diastolic pressure, lower mean pulmonary artery pressure, and higher mean arterial pressure. Earlier decompression also led to milder pulmonary blood congestion and pulmonary histopathology.</p><p><strong>Conclusion: </strong>Left heart decompression, when initiated as soon as possible during VA-ECMO, can protect pulmonary function by alleviating inflammatory responses in the lung, improving hemodynamics and lowering ventricular filling pressure.</p>\",\"PeriodicalId\":12414,\"journal\":{\"name\":\"Frontiers in Cardiovascular Medicine\",\"volume\":\"12 \",\"pages\":\"1545903\"},\"PeriodicalIF\":2.8000,\"publicationDate\":\"2025-09-24\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12504222/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Frontiers in Cardiovascular Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.3389/fcvm.2025.1545903\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q2\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Cardiovascular Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3389/fcvm.2025.1545903","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
Early left heart decompression protects the lungs in a canine model of acute left heart failure being treated with venoarterial extracorporeal membrane oxygenation.
Background: Nearly 30% of patients who undergo venoarterial extracorporeal membrane oxygenation (VA-ECMO) suffer pulmonary edema, which increases mortality risk. Left heart decompression is widely considered an effective way to counter left ventricular dilatation during VA-ECMO, but whether decompression can protect the lung or improve prognosis is unclear. We investigated this question using a canine model of acute left heart failure being treated through VA-ECMO.
Methods: The left anterior descending artery was ligated in 12 beagles to induce acute heart failure, and starting 1 h later, animals were treated using femoral-femoral VA-ECMO for 3 h. In half the animals, left heart decompression was initiated concurrently with VA-ECMO. In the other half, decompression was initiated 1 h after VA-ECMO began. The "early decompression" and "late decompression" groups were compared in terms of pulmonary function, cardiac function, hemodynamics, histopathology and inflammatory responses.
Results: Early initiation of decompression led to significantly higher PaO2 (63.27 ± 3.35 vs. 24.70 ± 4.44 mmHg, P = 0.030), lower PaCO2 (31.65 ± 2.87 vs. 41.02 ± 4.88 mmHg, P = 0.014), smaller alveolar-arterial oxygen pressure difference, weaker transpulmonary pressure gradient (3.67 ± 3.14 vs. 13.35 ± 4.26 mmHg, P = 0.017), milder pulmonary edema, lower levels of pro-inflammatory cytokines TNF-α and IL-6 in lungs, lower left atrial pressure, lower left ventricular end diastolic pressure, lower mean pulmonary artery pressure, and higher mean arterial pressure. Earlier decompression also led to milder pulmonary blood congestion and pulmonary histopathology.
Conclusion: Left heart decompression, when initiated as soon as possible during VA-ECMO, can protect pulmonary function by alleviating inflammatory responses in the lung, improving hemodynamics and lowering ventricular filling pressure.
期刊介绍:
Frontiers? Which frontiers? Where exactly are the frontiers of cardiovascular medicine? And who should be defining these frontiers?
At Frontiers in Cardiovascular Medicine we believe it is worth being curious to foresee and explore beyond the current frontiers. In other words, we would like, through the articles published by our community journal Frontiers in Cardiovascular Medicine, to anticipate the future of cardiovascular medicine, and thus better prevent cardiovascular disorders and improve therapeutic options and outcomes of our patients.